Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities. (Q50110295)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21481132%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21481132%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21481132%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Richard M Martin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21481132%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Chris Metcalfe

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21481132%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

4

Jenny L Donovan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21481132%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

3

Emma L Turner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21481132%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

5

Freddie C Hamdy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21481132%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Naomi Williams

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21481132%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Laura J Hughes

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21481132%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

11 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21481132%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21481132%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21481132%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21481132%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

1402-1408

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21481132%20AND%20SRC:MED&resulttype=core&format=json

Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?

28 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10163.X

Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10163.X

The changing face of low-risk prostate cancer: trends in clinical presentation and primary management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10163.X

Mortality results from a randomized prostate-cancer screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10163.X

Screening and prostate-cancer mortality in a randomized European study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10163.X

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10163.X

Feasibility and cost of obtaining informed consent for essential review of medical records in large-scale health services research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10163.X

Rates of prostate-specific antigen testing in general practice in England and Wales in asymptomatic and symptomatic patients: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10163.X

Excess cases of prostate cancer and estimated overdiagnosis associated with PSA testing in East Anglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10163.X

The increased rate of prostate specific antigen testing has not affected prostate cancer presentation in an inner city population in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10163.X

Effects of a prostate awareness pilot on GP consultations and PSA requests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10163.X

Survey of the rate of PSA testing in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10163.X

Are men with lower urinary tract symptoms at increased risk of prostate cancer? A systematic review and critique of the available evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10163.X

Guideline for the primary care management of male lower urinary tract symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10163.X

The prevalence of lower urinary tract symptoms in Austrian males and associations with sociodemographic variables.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10163.X

Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10163.X

Public awareness of cancer in Britain: a population-based survey of adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10163.X

Survival from prostate cancer in England and Wales up to 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10163.X

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10163.X

Population based time trends and socioeconomic variation in use of radiotherapy and radical surgery for prostate cancer in a UK region: continuous survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10163.X

Prostate Testing for Cancer and Treatment (ProtecT) feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10163.X

10.1111/J.1464-410X.2011.10163.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21481132%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference